LEVY ROBERT 4
4 · HERBALIFE NUTRITION LTD. · Filed Feb 16, 2021
Insider Transaction Report
Form 4
LEVY ROBERT
President
Transactions
- Tax Payment
Common Stock
2021-02-11$56.66/sh−30,538$1,730,283→ 540,236 total - Exercise/Conversion
Stock Appreciation Rights
2021-02-11−41,666→ 0 totalExercise: $26.64From: 2014-05-18Exp: 2021-05-18→ Common Stock (41,666 underlying) - Exercise/Conversion
Common Stock
2021-02-11$26.64/sh+41,666$1,110,191→ 570,774 total - Sale
Common Stock
2021-02-16$55.46/sh−11,128$617,166→ 529,108 total
Footnotes (4)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]This transaction was executed in multiple trades at prices ranging from $55.12 to $55.74. The price reported reflects the weighted average sale price of $55.4606. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering 20,833 shares at an exercise price of $53.29 per share.
- [F4]The SARS were granted on May 18, 2011. 20% vested on May 18, 2012, 20% vested on May 18, 2013 and the remaining 60% vested on May 18, 2014.